1. Home
  2. FRSH vs AMLX Comparison

FRSH vs AMLX Comparison

Compare FRSH & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

N/A

Current Price

$11.87

Market Cap

3.4B

Sector

Technology

ML Signal

N/A

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

N/A

Current Price

$32.09

Market Cap

3.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRSH
AMLX
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
FRSH
AMLX
Price
$11.87
$32.09
Analyst Decision
Buy
Strong Buy
Analyst Count
15
9
Target Price
$14.86
$21.56
AVG Volume (30 Days)
5.0M
3.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
296.88
65.46
EPS
N/A
N/A
Revenue
$838,809,000.00
$380,786,000.00
Revenue This Year
$16.30
N/A
Revenue Next Year
$14.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.43
1612.94
52 Week Low
$6.79
$10.83
52 Week High
$13.99
$41.14

Technical Indicators

Market Signals
Indicator
FRSH
AMLX
Relative Strength Index (RSI) 42.48 54.73
Support Level $11.62 $12.54
Resistance Level $12.28 $41.14
Average True Range (ATR) 0.41 1.80
MACD -0.26 -0.91
Stochastic Oscillator 6.61 6.80

Price Performance

Historical Comparison
FRSH
AMLX

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions. It derives maximum revenue from North America.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: